Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vir Biotechnology (VIR)
NASDAQ:VIR
Vir Biotechnology (VIR) Stock Forecast & Price Target
1,185 Followers
See the Price Targets and Ratings of:
VIR Analyst Ratings
Moderate Buy
6 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VIR Stock 12 Month Forecast
Average Price Target
$30.75
▲(247.46% Upside)
| Highest Price Target$110.00 | Average Price Target$30.75 | Lowest Price Target$13.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Morgan Stanley
Reiterated
06/20/24
Leerink Partners
Reiterated
06/09/24
Goldman Sachs
Reiterated
06/05/24
Bank of America Securities
Reiterated
06/05/24
H.C. Wainwright
Reiterated
06/05/24
Best Analysts Covering Vir Biotechnology
Which Analyst Should I Follow If I Want to Buy VIR and Sell After:
1 Month
3 Months
1 Year
Success Rate
4/25 ratings generated profit
Average Return
-34.40%
reiterated a buy rating 28 days ago
Copying Joseph Stringer's trades and holding each position for 1 Year would result in 16.00% of your transactions generating a profit, with an average return of -34.40% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VIR Analyst Recommendation Trends
Rating
Jan 24
Feb 24
Mar 24
May 24
Jun 24
Strong Buy
11
8
9
14
14
Buy
2
2
2
4
3
Hold
1
3
3
3
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
13
14
21
22
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
VIR Financial Forecast
VIR Stock Forecast FAQ
What is VIR’s average 12-month price target, according to analysts?
Based on analyst ratings, Vir Biotechnology’s 12-month average price target is $30.75.
What is VIR’s upside potential, based on the analysts’ average price target?
Vir Biotechnology has 247.46% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VIR a Buy, Sell or Hold?
Vir Biotechnology has a consensus rating of Moderate Buy which is based on 6 buy ratings, 3 hold ratings and 0 sell ratings.
What is Vir Biotechnology’s price target?
The average price target for Vir Biotechnology is $30.75. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $110.00 ,the lowest forecast is $13.00. The average price target represents 247.46% Increase from the current price of $8.85.
The highest analyst price target is $110.00 ,the lowest forecast is $13.00. The average price target represents 247.46% Increase from the current price of $8.85.
What do analysts say about Vir Biotechnology?
Vir Biotechnology’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of VIR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.